Avena Sativasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-12-10
Share capital
3 852 000,00 PLN
Registered address
ul. Kinga C. Gillette 11, 94-406 Łódź, Poland
Electronic delivery address
AE:PL-15088-91530-UDTWC-18

Financials

Revenue history (in k)

Financial insight

  • Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 — this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 7.03mMedianUSD 1.76mAverageUSD 4.96m
Net profit
This companyUSD -75.22kMedianUSD 17.49kAverageUSD 77.31k
Operating costs
This companyUSD 7.05mMedianUSD 1.72mAverageUSD 4.80m
Assets
This companyUSD 1.97mMedianUSD 495.60kAverageUSD 1.69m

Bank accounts

Registered as a VAT taxpayer on 2001-12-22. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,140
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$7,212
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$6,481

Tenders

No recorded participation in tenders.

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Aleksandra Olszacka — Vice President of the Management Board
Bożena Helena Szymańska — President of the Management Board
Katarzyna Nockowska Stańczak — Vice President of the Management Board

Manner of representation

If a multi-member management board is appointed, the validity of declarations submitted on behalf of the company requires the joint action of two members of the management board or a member of the management board jointly with a commercial proxy. The commercial proxy submits declarations on behalf of the company jointly with a member of the management board or, if joint commercial proxy has been granted, with another commercial proxy.

Ownership

OwnerSharesShare valueStake
1,849$249,729.8824.0005%
5,855$790,788.7675.9995%

Beneficial owners

Person
Zbigniew Jacek Molenda (63)
Jacek Romuald Szwajcowski (62)

Competitors

Name
MybestpharmS.A.
Fragalsp. z o.o.
Modrzewscysp. j.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Pikadasp. z o.o.
Awicennasp. j.

Change history

DateEvent
2024-11-20Address change
2018-01-03Share capital change
2008-03-18Share capital change
2007-09-05Share capital change
2001-12-10Entered in the register

FAQ

Last updated: 2026-06-14